Background: Celiac plexus neurolysis (CPN) is an effective but temporary management tool for pancreatic cancer pain (PCP). Clinical studies have shown the duration of benefit with initial CPN to be approximately 3 months. When pain recurs, CPN may be repeated, but the outcomes for repeat CPN are not well established. The objective of this study is to determine the success rate and duration of relief follow-ing repeat celiac plexus neurolysis (rCPN) for PCP. Methods: Patients who underwent rCPN were identified from a database and their records reviewed. Responses of rCPN were then compared with iCPN for success rates and duration of relief. Success was defined as ‡ 50 % pain relief lasting ‡ 1 month. Results: Overall, there were 24 rCPN perf...
BACKGROUND: Intraperitoneal hyperthermic chemoperfusion (IHCP), which is a locoregional treatment us...
Background: The aim of this study was to evaluate the survival rate of patients with endocrine tumor...
The purpose of this study was to evaluate the outcome of adjuvant chemoradiotherapy (CRT) after dist...
Background: Celiac plexus neurolysis (CPN) is an effective but temporary management tool for pancrea...
Background: Celiac plexus neurolysis (CPN) is an effective but temporary management tool for pancrea...
Introduction:. Celiac plexus neurolysis (CPN) has been verified for mitigating pancreatic cancer pai...
István Molnár,1 Gabriella Hegyi,1,2 Lajos Zsom,3 Christine Saahs,4,5 Jan Vagedes,6,7 G...
Context Chronic abdominal pain is the most difficult management issue in patients with chronic pancr...
Context Pancreatic exocrine insufficiency is a significant problem after acute pancreatitis. Objecti...
The effective management of pancreatic cancer pain continues to be a major challenge for patients an...
BACKGROUND: Neurolytic celiac plexus block (NCPB) is a safe and effective method for reducing abdomi...
Purpose: Survival outcome of locally advanced pancreatic cancer has been poor and little is known ab...
Neurolytic celiac plexus block (NCPB) is claimed to be an effective method of pain control for pancr...
Background: Advanced pancreatic cancer is a rapidly fatal disease whose course has been little influ...
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-C...
BACKGROUND: Intraperitoneal hyperthermic chemoperfusion (IHCP), which is a locoregional treatment us...
Background: The aim of this study was to evaluate the survival rate of patients with endocrine tumor...
The purpose of this study was to evaluate the outcome of adjuvant chemoradiotherapy (CRT) after dist...
Background: Celiac plexus neurolysis (CPN) is an effective but temporary management tool for pancrea...
Background: Celiac plexus neurolysis (CPN) is an effective but temporary management tool for pancrea...
Introduction:. Celiac plexus neurolysis (CPN) has been verified for mitigating pancreatic cancer pai...
István Molnár,1 Gabriella Hegyi,1,2 Lajos Zsom,3 Christine Saahs,4,5 Jan Vagedes,6,7 G...
Context Chronic abdominal pain is the most difficult management issue in patients with chronic pancr...
Context Pancreatic exocrine insufficiency is a significant problem after acute pancreatitis. Objecti...
The effective management of pancreatic cancer pain continues to be a major challenge for patients an...
BACKGROUND: Neurolytic celiac plexus block (NCPB) is a safe and effective method for reducing abdomi...
Purpose: Survival outcome of locally advanced pancreatic cancer has been poor and little is known ab...
Neurolytic celiac plexus block (NCPB) is claimed to be an effective method of pain control for pancr...
Background: Advanced pancreatic cancer is a rapidly fatal disease whose course has been little influ...
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-C...
BACKGROUND: Intraperitoneal hyperthermic chemoperfusion (IHCP), which is a locoregional treatment us...
Background: The aim of this study was to evaluate the survival rate of patients with endocrine tumor...
The purpose of this study was to evaluate the outcome of adjuvant chemoradiotherapy (CRT) after dist...